A new metal-on-metal hip implant has been removed from the market because of unacceptably high revision rates and safety concerns. Medical device manufacturer Zimmer Holdings pulled its metal-on-metal Durom acetabular hip implants from the Australian Register of Therapeutic Goods (ARTG) after data showed high revision rates.

Data showed that the Durom hip implant had a 9.6 percent revision rate at 7 years in hip resurfacing procedures, and a 6.8 percent revision rate at 5 years in total hip replacement procedures. Zimmer issued a “hazard alert” to doctors who had used the device, although the Durom components are already infrequently used.

According to data from the ARTG, the last recorded surgery using a Durom device took place in June 2011. Use of the implant has declined in Australia since 2005. According to Zimmer spokesman Garry Clark, Durom sales are also “negligible” in the U.S.

Clark attributes the decreased demand and the ultimate removal of the Durom hip components from market to be linked to the increasing safety concerns about metal-on-metal hip implants, which have been linked to adverse effects and high revision surgery rates.

Numerous studies have concluded that the metal components of the hip implants can corrode, causing toxic metal ions to release into the surrounding bloodstream. This can lead to pain, inflammation, tissue damage, and ultimately cause hip replacement failure in patients. Metal poisoning can even lead to other symptoms elsewhere in the body, affecting the heart, nervous system and thyroid gland.

The FDA has received an estimated 17,000 reports from patients who experienced complications after receiving an all-metal hip implant. 14,121 of those patients had to undergo revision surgery. In August 2010, Johnson & Johnson subsidiary DePuy Orthopaedics issued a DePuy ASR hip recall after data showed that 1 out of 8 implants failed within a few years after surgery.

However, many other metal hip replacement implants remain on the market despite safety problems. In June this year, the FDA convened a panel to evaluate the dangers of metal hip implants. Although many experts and orthopedic surgeons argued against using the devices, the FDA did not issue an official recommendation or a recall.

Patients who experienced problems from a metal hip implant are taking matters into their own hands and filing lawsuits against the hip manufacturers to seek compensation for their injuries. Our firm currently represents clients injured by the following hip systems:

In addition, we are also investigating cases brought by patients who suffered hip implants with recalled Stryker Rejuvenate and ABG II hip components.

Learn more about how you can file a lawsuit and seek compensation for your medical expenses, lost wages, pain and suffering by calling a hip replacement lawyer: (877) 779-1414.

Published November 30, 2012 by